Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy

Erik Hedrick(Florida Agricultural and Mechanical University), Stephen Safe(Texas A&M Health Science Center)
Endocrine Related Cancer
July 30, 2015
Cited by 59


Related Papers